Glucocorticoids modulate signal transduction mechanisms in a number of
cell systems. As the adrenal medulla is exposed to relatively high le
vels of adrenal cortical glucocorticoids in vivo, particularly during
periods of stress, the aim of the present study was to determine wheth
er glucocorticoids modulate cyclic AMP (cAMP) metabolism in an in vitr
o model of this system, the PC18 cell line. Dexamethasone significantl
y potentiated cAMP accumulation in response to the adenosine analogue
N-6-R-phenylisopropyl adenosine (PIA), and in response to forskolin. T
his effect was both time- and concentration-dependent. Maximal potenti
ation was observed after 48 h of exposure to 1 mu M dexamethasone. Cor
ticosterone and to a lesser extent aldosterone also significantly pote
ntiated PIA-dependent cAMP accumulation. In contrast, estradiol, testo
sterone, and triiodothyronine had no potentiative effect. Potentiation
could be eliminated by coincubation with the protein synthesis inhibi
tor cycloheximide. In the presence of Po 20-1724, a cAMP-phosphodieste
rase inhibitor, the degree of potentiation of both PIA- and forskolin-
dependent cAMP accumulation was significantly decreased by 50-60%. The
se data suggested that altered cAMP-phosphodiesterase activity may be
involved in this response. However, cytosolic and membrane-bound low K
-m cAMP-phosphodiesterase activity was unchanged in dexamethasone-trea
ted cells compared with controls. Similarly, there were no significant
differences in basal, PIA-, forskolin-, or GTP gamma S-stimulated ade
nylate cyclase activities between groups. These studies indicate that
glucocorticoids can potentiate cAMP accumulation in intact PC18 cells.
The mechanism underlying this potentiation is likely to be multifacto
rial, but may be due in part to decreased cAMP catabolism.